CLASS II Drug recall · Reported 20 Feb 2019 · FDA Enforcement Report

Labetalol 20mg, HCL, USP Injectable Solution, 20mg recalled

Avella of Deer Valley Inc. Store 38 is recalling Labetalol 20mg, HCL, USP Injectable Solution, 20mg/ (5 mg per mL) single use syringe, distributed in 13 states. The recall was initiated on 8 Feb 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codes138-20182712@49, BUD 4/6/2019; 138-20182712@63, BUD 4/6/2019; 138-20182712@89, BUD 4/6/2019; 138-20182712@90, BUD 4/6/2019; 138-20182712@93, BUD 4/6/2019; 138-20183112@88, BUD 4/10/2019; 138-20183112@89, BUD 4/10/2019;138-20183112@91, BUD 4/10/2019; 138-20190201@96, BUD 4/12/2019
Quantity recalled2,840 4mL syringes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0997-2019
FDA event ID
82102
Recalling firm
Avella of Deer Valley Inc. Store 38, Phoenix, AZ
Classification
Class II
Status
Terminated
Recall initiated
8 Feb 2019
FDA classified
12 Mar 2019
Reported
20 Feb 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

8 Feb 2019Recall initiated by company
20 Feb 2019Published in enforcement report+12 days
12 Mar 2019Classified by FDA+20 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date:The product labels contain a Two-Dimensional ( 2D ) barcode that, when scanned, reveals information specific to the batch of the labeled product, including Expiration Date. The expiration date included within these 2D barcodes is incorrect and does not match the correct expiration date listed on the face of the label itself.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Labetalol 20mg, HCL, USP Injectable Solution, 20mg/4mL (5 mg per mL), 4mL single use syringe. Repackaged by Avella Specialty Pharmacy 24416 N 19th Avenue, Phoenix, AZ 85085 (877) 794-0404, NDC 42852-822-71.

Where it was distributed

Distribution to 13 states: Alabama, Arizona, California, Colorado, Florida, Idaho, Michigan, Minnesota, North Carolina, New Jersey, Oregon, Pennsylvania, Texas.

AlabamaArizonaCaliforniaColoradoFloridaIdahoMichiganMinnesotaNorth CarolinaNew JerseyOregonPennsylvaniaTexas

Questions about this recall

Why was it recalled?

Labeling: Incorrect or Missing Lot and/or Exp Date:The product labels contain a Two-Dimensional ( 2D ) barcode that, when scanned, reveals information specific to the batch of the labeled product, including Expiration Date. The expiration date included within these 2D barcodes is incorrect and does not match the correct expiration date listed on the face of the label itself.

Which lots are affected?

138-20182712@49, BUD 4/6/2019; 138-20182712@63, BUD 4/6/2019; 138-20182712@89, BUD 4/6/2019; 138-20182712@90, BUD 4/6/2019; 138-20182712@93, BUD 4/6/2019; 138-20183112@88, BUD 4/10/2019; 138-20183112@89, BUD 4/10/2019;138-20183112@91, BUD 4/10/2019; 138-20190201@96, BUD 4/12/2019

Where was it sold?

Distribution to 13 states: Alabama, Arizona, California, Colorado, Florida, Idaho, Michigan, Minnesota, North Carolina, New Jersey, Oregon, Pennsylvania, Texas.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

3 other products · FDA event 82102

This product is part of a recall event; the main page for the event is MAGnesium 2 gm sulfate, added to NS, Sterile single use recalled.

More recalls from Avella of Deer Valley Inc. Store 38

All 50

Other Labetalol recalls

All 16